Post engagements
Back to post- Congrats Dr. Jingxuan Zhao on leading this important and timely study. The findings highlight the urgent need for policies that expand insurance coverage and improve access to life-saving treatments.
- The introduction of immune checkpoint inhibitors was associated with improved survival for advanced-stage melanoma, non-small cell lung cancer, and renal cell carcinoma across all insurance types. ja.ma/404o3Tn
